The Clorox Company CLX
83.80
2.00
2.44%
as of 25 Sep
- Market cap
- $10.0B
- P/E
- 17.4×
Follow CLX
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
The Clorox Company (CLX) Revenue
The Clorox Company's revenue for fiscal 2026 was $6.7B, down 5.41% from $7.1B in fiscal 2025. Over the past ten years it has ranged from $5.7B (fiscal 2015) to $7.4B (fiscal 2023); the current reading is higher than 50% of that period. The Clorox Company ranks 8th of 28 Household & Personal Products companies by revenue.
Revenue, annual
Annual
| Period | Revenue | Change |
|---|---|---|
| FY2026 | $6.7B | (5.41%) |
| FY2025 | $7.1B | 0.16% |
| FY2024 | $7.1B | (4.01%) |
| FY2023 | $7.4B | 3.97% |
| FY2022 | $7.1B | (3.19%) |
| FY2021 | $7.3B | 9.22% |
| FY2020 | $6.7B | 8.16% |
| FY2019 | $6.2B | 1.47% |
| FY2018 | $6.1B | 2.53% |
| FY2017 | $6.0B | 3.68% |
Quarterly
| Period | Revenue | Change |
|---|---|---|
| Jun 2026 | $1.9B | 16.65% |
| Mar 2026 | $1.7B | (0.18%) |
| Dec 2025 | $1.7B | 17.07% |
| Sep 2025 | $1.4B | (28.12%) |
| 42 more quarters | Free account |
Against its own ten years
Low $5.7B
High $7.4B
Ten-year median
$6.7B
Current reading's percentile
50
Revenue against peers
| Company | Revenue |
|---|---|
| KMB Kimberly-Clark Corporation compare | $16.6B |
| KVUE Kenvue Inc. compare | $15.4B |
| EL The Estee Lauder Companies Inc. compare | $15.0B |
| NWL Newell Brands Inc. compare | $7.2B |
| CLX The Clorox Company | $6.7B |
| CHD Church & Dwight Co., Inc. compare | $6.2B |
| COTY Coty compare | $5.8B |
| ELF e.l.f. Beauty compare | $1.8B |
| IPAR Interparfums, Inc. compare | $1.5B |
What Revenue is
Revenue tells an investor how much a company brought in from selling its goods and services over a period, before any costs are taken out.
Reported line item
More on CLX
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement